NOVO NORDISK A/S Bagsværd, Denmark, 1 April 2015 - In continuation of the company's announcements dated 30 October 2014 and 30 January 2015 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 31 March 2015 owned 67,108,333 of its own B shares of DKK 0.20, corresponding to a total nominal value of DKK 13,421,667 or 2.5% of the total share capital.
Further information
| Media: | ||
| Anne Margrethe Hauge | +45 3079 3450 | amhg@novonordisk.com |
| Investors: | ||
| Kasper Roseeuw Poulsen | +45 3079 4303 | krop@novonordisk.com: mailto:krop@novonordisk.com |
| Daniel Bohsen | +45 3079 6376 | dabo@novonordisk.com: mailto:dabo@novonordisk.com |
| Melanie Raouzeos | +45 3075 3479 | mrz@novonordisk.com: mailto:mrz@novonordisk.com |
| Frank Daniel Mersebach (US) | +1 609 235 8567 | fdni@novonordisk.com: mailto:fdni@novonordisk.com |
Company announcement No 25 / 2015
Company announcement No 25 / 2015:
http://hugin.info/2013/R/1908264/679982.pdf
http://hugin.info/2013/R/1908264/679982.pdf
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Globenewswire
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Globenewswire
HUG#1908264
